Trial reportJournal of cosmetic dermatology2025
Assessment of Hyaluronic Acid Filler in Gluteal Augmentation and Contouring: A 1-Year Prospective Study.
Trial report in Journal of cosmetic dermatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMinimally invasive gluteal augmentation techniques have gained popularity as alternatives to surgical procedures, offering reduced downtime and an improved safety profile. Hyaluronic acid (HA) fillers have emerged as a promising option due to their biocompatibility and favorable rheological characteristics.
objectivesTo evaluate safety, efficacy, durability, and patient satisfaction of a cross-linked HA filler for gluteal augmentation and contouring over a 12-month period, and to conduct a pilot exploratory substudy assessing serum HA levels up to 90 days.
methodsThis was a 12-month, prospective, multicenter, open-label study including 30 healthy women undergoing gluteal augmentation with a cross-linked HA filler (UP Max). Each participant received up to 60 mL of HA filler, administered using a quadrant-based technique, guided by anatomical landmarks. Outcomes included safety (adverse events), efficacy (standardized photography and 3D imaging, ultrasound), durability and patient satisfaction. In addition, serum HA levels were measured in a pilot subgroup of patients.
resultsThe mean injected volume was 43.60 ± 11.48 mL. Patient satisfaction peaked at Day 30 (90%) and declined to 62% at 12 months, consistent with HA biodegradation. Ultrasound confirmed subcutaneous placement and progressive filler absorption and integration, with no signs of migration, fibrosis or nodularity. Serum HA levels showed a transient increase at Day 30 and returned to near baseline at Day 90. No serious adverse events were reported, and minor complications were infrequent.
conclusionsHA filler demonstrated a favorable safety profile, high patient satisfaction, and aesthetic improvements over 1 year. These findings support its use as a safe and effective option for nonsurgical gluteal augmentation and body contouring.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.